RXO, Inc.
RXO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $3 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $0 |
| Enterprise Value | $4 | $3 | $3 | $3 |
| Revenue | $5 | $4 | $5 | $5 |
| % Growth | 15.9% | -18.1% | 2.3% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 17.2% | 18.5% | 17.9% | 15.7% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 2.6% | 3.4% | 4.4% | 5.8% |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -6.4% | 0.1% | 1.9% | 3.2% |
| EPS Diluted | -2.17 | 0.034 | 0.79 | 1.29 |
| % Growth | -6,577.6% | -95.8% | -38.8% | – |
| Operating Cash Flow | -$0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | $0 | $0 |